Ceres Ventures, Inc. (CEVE) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ceres Ventures, Inc. (CEVE) trades at $0.0001 with AI Score 42/100 (Grade C). Ceres Ventures, Inc. is a development stage company focused on clean technology solutions for water, soil, and air remediation. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for CEVE: CEVE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CEVE against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CEVE: the 3 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Ceres Ventures, Inc. (CEVE) Healthcare & Pipeline Overview
Ceres Ventures, Inc., a development stage company, focuses on developing and commercializing clean technologies for environmental remediation, particularly in water treatment. Their BluFlow technologies aim to remove contaminants and extract valuable elements, positioning them within the growing market for sustainable water solutions. The company operates in the healthcare sector.
What Is the Investment Thesis for CEVE?
Ceres Ventures, Inc. presents a high-risk, high-reward investment profile typical of development stage companies in the clean technology sector. The company's BluFlow technologies target a significant market opportunity in water remediation and resource extraction. However, the company's lack of revenue and reliance on future commercialization pose substantial risks. Key value drivers include successful deployment and adoption of BluFlow technologies, securing partnerships, and obtaining regulatory approvals. The negative beta of -101.80 suggests an inverse correlation with the market, which is unusual and may reflect the company's speculative nature and limited trading activity. Investors should carefully consider the risks associated with development stage companies and the uncertainties surrounding the commercial viability of Ceres Ventures, Inc.'s technologies.
Based on FMP financials and quantitative analysis
CEVE Key Highlights
Ceres Ventures, Inc. is a development stage company focused on clean technology solutions.
- The company's core technologies include BluFlow Nanoparticles and Advanced Ultrafiltration.
- Ceres Ventures, Inc. targets the water remediation and resource extraction market.
- The company has a negative P/E ratio of -0.02, indicating it is not currently profitable.
- The company's beta is -101.80, indicating an inverse correlation with the market.
Who Are CEVE's Competitors?
CEVE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BICX BioCorRx Inc. | $0.24 | +0.00% | $6.34M | 52 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| CANO Cano Health, Inc. | $2.30 | -2.13% | $12.4M | 52 |
| NVLPF Nova Leap Health Corp. | $0.36 | +5.30% | $31.4M | 55 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.4M | 63 |
| BTMD biote Corp. | $1.44 | +5.88% | $63.5M | 66 |
| JYNT The Joint Corp. | $8.25 | +0.24% | $118M | 75 |
| HWAIF Healwell AI Inc. | $0.57 | +3.64% | $172M | 65 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CEVE's Key Strengths?
Proprietary BluFlow technology
- Customizable solutions for specific applications
- Potential for resource extraction from water
- Focus on a growing market for sustainable solutions
What Are CEVE's Weaknesses?
Development stage company with limited revenue
- Reliance on future commercialization
- Limited financial resources
- Unproven track record
What Could Drive CEVE Stock Higher?
Successful completion of pilot projects demonstrating the effectiveness of BluFlow technologies.
- Securing partnerships with municipal water treatment facilities or industrial clients.
- Obtaining regulatory approvals for BluFlow technologies in key markets.
- Continued research and development of BluFlow technologies to enhance performance and expand applications.
- Increasing awareness of water scarcity and the need for sustainable water solutions.
What Are the Key Risks for CEVE?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Development stage company with limited revenue and unproven track record.
- Competition from established water treatment companies with greater resources.
- Technological advancements by competitors rendering BluFlow technologies obsolete.
- Regulatory changes impacting water treatment standards and requiring costly compliance measures.
- Economic downturn affecting investment in clean technology and delaying commercialization.
What Are the Growth Opportunities for CEVE?
- Expansion into Industrial Wastewater Treatment: The industrial sector generates significant volumes of wastewater containing various pollutants. Ceres Ventures, Inc. can leverage its BluFlow technology to offer customized solutions for industrial wastewater treatment, targeting specific contaminants and enabling water reuse. The market for industrial wastewater treatment is substantial, driven by stringent environmental regulations and the increasing cost of water disposal. This represents a significant growth opportunity for Ceres Ventures, Inc., with potential for long-term contracts and recurring revenue streams.
- Partnerships with Municipal Water Treatment Facilities: Municipal water treatment facilities face challenges in removing emerging contaminants and meeting increasingly stringent water quality standards. Ceres Ventures, Inc. can partner with municipalities to deploy its BluFlow Treatment System, enhancing the efficiency and effectiveness of existing water treatment processes. This partnership model allows Ceres Ventures, Inc. to access a large and stable market, while providing municipalities with innovative solutions for water purification.
- Development of Specialized Nanoparticles for Resource Extraction: Ceres Ventures, Inc. can expand its BluFlow Nanoparticle technology to target the extraction of valuable elements and compounds from water-based solutions, such as rare earth elements and precious metals. This application addresses the growing demand for these resources and provides a sustainable alternative to traditional mining methods. The market for resource extraction from water is emerging, offering significant growth potential for Ceres Ventures, Inc.
- Geographic Expansion into Water-Stressed Regions: Water scarcity is a growing global challenge, particularly in arid and semi-arid regions. Ceres Ventures, Inc. can expand its operations into these regions, offering its BluFlow technologies for water purification, wastewater treatment, and water reuse. This geographic expansion allows Ceres Ventures, Inc. to address a critical need and capitalize on the increasing demand for sustainable water solutions in water-stressed areas.
- Securing Government Funding and Grants: Government agencies and organizations are increasingly investing in clean technology solutions for environmental remediation. Ceres Ventures, Inc. can actively pursue government funding and grants to support its research, development, and commercialization efforts. This funding can accelerate the development of its BluFlow technologies and facilitate their deployment in pilot projects and commercial applications.
What Are CEVE's Competitive Advantages?
- Proprietary BluFlow Nanoparticle technology
- Customizable solutions for targeted contaminant removal
- Integrated treatment system combining nanoparticles and ultrafiltration
- Potential for intellectual property protection through patents
What Does CEVE Do?
Ceres Ventures, Inc., formerly known as PhytoMedical Technologies, Inc. until November 2011, is a development stage company dedicated to the research, development, and commercialization of clean technologies. Headquartered in New York City, the company focuses on remediating polluted water, soil, and air through innovative solutions. Their primary technologies revolve around the BluFlow system, encompassing BluFlow Nanoparticles, BluFlow Advanced Ultrafiltration Technology, and the BluFlow Treatment System. The BluFlow Nanoparticles are a proprietary system designed for formulating, producing, and deploying customizable absorbent nanoparticles. These nanoparticles are engineered for specific functionalities, enabling the removal of contaminants and chemicals, as well as the extraction of valuable elements and compounds from water-based solutions. The BluFlow Advanced Ultrafiltration Technology is an automated process aimed at recovering water from waste or impure streams, enhancing water reuse possibilities. The BluFlow Treatment System integrates both Nanoparticles and Ultrafiltration technologies to provide a comprehensive water and wastewater treatment solution, removing target elements, compounds, and pollutants to purify water for potential reuse. Ceres Ventures, Inc.'s technologies find application in various sectors, including water and wastewater treatment and purification, contaminated groundwater treatment, industrial wastewater treatment, and the extraction of valuable elements and compounds. As a development stage company, Ceres Ventures, Inc. is focused on further developing and commercializing its technologies to address the growing demand for sustainable environmental solutions.
What Products and Services Does CEVE Offer?
- Researches and develops clean technologies for environmental remediation.
- Focuses on water, soil, and air pollution solutions.
- Develops BluFlow Nanoparticles for contaminant removal and resource extraction.
- Offers BluFlow Advanced Ultrafiltration Technology for water recovery.
- Provides BluFlow Treatment System for water and wastewater purification.
- Targets applications in water treatment, groundwater treatment, and industrial wastewater treatment.
How Does CEVE Make Money?
- Develop and commercialize clean technology solutions.
- Generate revenue through the sale of BluFlow Nanoparticles, Ultrafiltration Technology, and Treatment Systems.
- Seek partnerships with municipalities and industrial clients.
- Potentially generate revenue through licensing agreements.
What Industry Does CEVE Operate In?
Ceres Ventures, Inc. operates within the environmental remediation and water treatment industry, a sector driven by increasing environmental regulations, growing water scarcity, and the need for sustainable resource management. Competitors include companies like ASFX, CBGI, HSMD, LOWLF, and MDIT, which offer various water treatment solutions. Ceres Ventures, Inc. aims to differentiate itself through its BluFlow technologies, offering customizable nanoparticle solutions for targeted contaminant removal and resource extraction.
Who Are CEVE's Key Customers?
- Municipal water treatment facilities
- Industrial companies generating wastewater
- Government agencies involved in environmental remediation
- Companies involved in resource extraction from water
How Ceres Ventures, Inc. Is Valued
Relative to its peer group, CEVE's quantitative score of 42/100 is below the peer average of 57/100.
Company Profile
Ceres Ventures, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in New York City, US. The company is led by CEO Frank J. Fabio. CEVE has traded publicly since 1995.
Key Financial Metrics
Return on equity for Ceres Ventures, Inc. stands at 225.9%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.21 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Ceres Ventures, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
CEVE Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Proprietary BluFlow technology
- Customizable solutions for specific applications
- Potential for resource extraction from water
- Focus on a growing market for sustainable solutions
Bear Case
- Development stage company with limited revenue
- Reliance on future commercialization
- Limited financial resources
- Unproven track record
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
CEVE Latest News
No recent news available for CEVE.
CEVE Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CEVE.
Price Targets
Wall Street price target analysis for CEVE.
CEVE MoonshotScore
What does this score mean?
The MoonshotScore rates CEVE 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Frank J. Fabio
CEO
Frank J. Fabio serves as the CEO of Ceres Ventures, Inc. His professional background and experience prior to joining Ceres Ventures are Unknown. As CEO, he is responsible for leading the company's strategic direction, overseeing operations, and driving the commercialization of its BluFlow technologies. His leadership is crucial in navigating the challenges of a development stage company and securing partnerships for growth.
Track Record: Frank J. Fabio's track record at Ceres Ventures, Inc. is difficult to assess due to the company's development stage and lack of significant commercial activity. Key milestones under his leadership would include securing funding, advancing the development of BluFlow technologies, and establishing partnerships. Further information is needed to evaluate his performance and strategic decisions.
CEVE OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, characterized by speculative securities with limited or no financial disclosure. Companies in this tier may not meet minimum financial standards or reporting requirements, leading to increased risk for investors. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies are not subject to stringent listing standards, resulting in less transparency and regulatory oversight. Investing in OTC Other stocks carries significant risks due to the lack of information and potential for fraud or manipulation.
- OTC Tier: OTC Other
- Limited or no financial disclosure
- Low liquidity and wide bid-ask spreads
- Potential for fraud or manipulation
- Lack of regulatory oversight
- Speculative nature of the securities
- Verify the company's registration and legal standing
- Obtain and review any available financial information
- Assess the company's business model and market opportunity
- Evaluate the management team and their experience
- Understand the risks associated with the company's industry
- Consult with a financial advisor
- Be prepared to lose your entire investment
- Company website and contact information
- Press releases and news coverage
- Any available financial reports or disclosures
- Information on management team and board members
- Independent verification of claims and technologies
What Investors Ask About Ceres Ventures, Inc. (CEVE) — Healthcare
What does the AI Score mean for CEVE?
CEVE holds an AI Score of 42/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Ceres Ventures, Inc. is a development stage company focused on clean technology solutions for water, soil, and air remediation. Their core technologies include BluFlow Nanoparticles and Advanced …
What does Ceres Ventures, Inc. do?
Ceres Ventures, Inc. is a development stage company focused on developing and commercializing clean technologies for environmental remediation, particularly in water treatment. Their core technologies, known as BluFlow, include customizable nanoparticles and advanced ultrafiltration systems designed to remove contaminants and extract valuable elements from water. The company aims to provide sustainable solutions for water purification, wastewater treatment, and resource recovery, targeting municipal, industrial, and governmental clients.
What do analysts say about CEVE stock?
As of March 16, 2026, there is no available analyst coverage or consensus on Ceres Ventures, Inc. (CEVE) stock. This is likely due to the company's development stage, limited trading activity on the OTC market, and lack of financial disclosure. Investors should conduct their own thorough research and consider the risks associated with investing in a speculative, thinly traded stock with limited information.
What are the main risks for CEVE?
The main risks for Ceres Ventures, Inc. include its development stage status, limited revenue, and reliance on future commercialization. Competition from established water treatment companies, technological advancements by competitors, and regulatory changes also pose significant risks.
What are the key factors to evaluate for CEVE?
Ceres Ventures, Inc. (CEVE) holds an AI score of 42/100 (low). presents a high-risk, high-reward investment profile typical of development stage companies in the clean technology sector. Not financial advice.
How frequently does CEVE data refresh on this page?
CEVE's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CEVE's recent stock price performance?
Ceres Ventures, Inc. (CEVE) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary BluFlow technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CEVE overvalued or undervalued right now?
Ceres Ventures, Inc. (CEVE) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research CEVE before investing?
Before investing in Ceres Ventures, Inc. (CEVE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available sources and may be limited due to the company's development stage and OTC listing.
- Financial data may not be current or readily available.